Type 2 diabetes D-allulose
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. patients with type 2 diabetes who are 20 years of age or older at the time of obtaining consent 2. patients with type 2 diabetes who are hospitalized in our hospital. 3. patients who can give written consent to participate in this study.
Exclusion criteria
Exclusion criteria: 1. patients taking alpha-glucosidase inhibitors 2. patients who have experienced serious adverse reactions to D-alulose in the past 3. pregnant, lactating, or nursing women, or women of childbearing potential 4. patients with severe renal dysfunction (serum eGFR < 15 ml/min/1.73m2) 5. patients with other serious complications 6. patients who are participating in other studies 7. if, in the opinion of the Principal Investigator, participation in the research would not be in the best interest of the research subjects (e.g., would be detrimental to the welfare of the research subjects) or would interfere with, limit, or confound the evaluation specific to the clinical research protocol 8. an employee of the Principal Investigator or the institution, or a family member of such an employee or Principal Investigator, who is directly involved in this or other clinical research at the direction of the Principal Investigator or the institution.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Use a continuous glucose meter to compare peak postprandial blood glucose levels. | — |
Secondary
| Measure | Time frame |
|---|---|
| Percentage of AUC, TIR, TAR, and TBR for 2 hours of postprandial blood glucose when using a continuous glucose meter Comparison of average blood glucose levels every 15 minutes up to 180 minutes after ingestion of each jelly group Comparison of average IRI, CPR, and TG values before and 120 minutes after consumption of each jelly group Patient satisfaction questionnaire including taste, etc. Changes in body weight Change in oral conditions | — |
Contacts
Kagawa university